Sanara MedTech Inc. (SMTI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sanara MedTech Inc.

    NASDAQ: SMTI · Real-Time Price · USD
    33.57
    -0.47 (-1.38%)
    At close: Sep 05, 2025, 3:59 PM
    33.57
    0.00%
    After-hours: Sep 05, 2025, 04:41 PM EDT

    Sanara MedTech Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 86.67M 64.99M 45.84M 24.14M
    Cost of Revenue
    		 8.14M 7.85M 6.36M 2.31M
    Gross Profit
    		 78.53M 57.14M 39.48M 21.83M
    Operating Income
    		 -6.72M -4.22M -12.23M -7.38M
    Interest Income
    		 21.98K n/a 284.75K n/a
    Pretax Income
    		 -9.91M -4.44M -13.94M -7.99M
    Net Income
    		 -9.66M -4.3M -7.94M -7.92M
    Selling & General & Admin
    		 76.56M 56.99M 45.98M 28.05M
    Research & Development
    		 5.7M 4.13M 3.37M 558.7K
    Other Expenses
    		 2.98M 225.13K 2.37M 596.98K
    Operating Expenses
    		 85.25M 61.35M 51.71M 29.21M
    Interest Expense
    		 3.13M 475.78K 284.75K 711.00
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 93.39M 69.2M 58.08M 31.52M
    Income Tax Expense
    		 247.35K n/a -5.84M n/a
    Shares Outstanding (Basic)
    		 8.48M 8.28M 7.91M 7.34M
    Shares Outstanding (Diluted)
    		 8.48M 8.28M 7.91M 7.34M
    EPS (Basic)
    		 -1.14 -0.52 -1 -1.08
    EPS (Diluted)
    		 -1.14 -0.52 -1 -1.08
    EBITDA
    		 -1.86M -289.1K -9.67M -7.22M
    EBIT
    		 -6.78M -3.96M -13.94M -7.99M
    Depreciation & Amortization
    		 4.92M 3.68M 2.37M 771.93K

    Add to Watchlist